Współczesna Onkologia

Clinical applications of artificial intelligence in oncology treatment planning

Zhanat Sadibekova 1
,
Gulbanu Arynova 2
,
Lazzat Niyazbekova 3
,
Gulden Yelgondina 4
,
Ayauly Iliyassova 4

  1. Department of Social Health Insurance and Public Health, South Kazakhstan Medical Academy, Shymkent, Kazakhstan

  2. Department of Epidemiology, Biostatistics and Evidence-Based Medicine, Farabi University, Almaty, Kazakhstan

  3. Department of Pathological Physiology named after Professor A.N. Nurmukhambetov, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan

  4. School of General Medicine-2, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan

Contemp Oncol (Pozn) 2026; 30 (3)

DOI: https://doi.org/10.5114/wo.2026.165835
Data publikacji online: 2026/10/23
Article file
Clinical applications.pdf
  1. Sadowski B, Milewska K, Ginter J. Machine learning based prediction of gamma passing rate for VMAT radiotherapy plans. J Pers Med 2022; 12: 2071.
  2. Wilk AM, Kozłowska E, Borys D, D’Amico A, Fujarewicz K, Gorczewska I, et al. Radiomic signature accurately predicts the risk of metastatic dissemination in late-stage non-small cell lung cancer. Transl Lung Cancer Res 2023; 12: 1372-1383.
  3. Kot E, Krawczyk Z, Siwek K, Krolicki L, Czwarnowski P. Deep learning based framework for tumour detection and semantic segmentation. Bull Pol Acad Sci Tech Sci 2021; 69: 136750.
  4. Jeziorski K, Olszewski R. Artificial intelligence in oncology. Appl Sci 2025; 15: 269.
  5. McIntosh C, Conroy L, Tjong MC, Craig T, Bayley A, Catton C, et al. Clinical integration of machine-learning for curative-intent radiation treatment of patients with prostate cancer. Nat Med 2021; 27: 999-1005.
  6. Court LE, Aggarwal A, Jhingran A, Naidoo K, Netherton T, Olanrewaju A, et al. Artificial intelligence – based radiotherapy contouring and planning to improve global access to cancer care. JCO Glob Oncol 2024; 10: 2300376.
  7. Kawamura M, Kamomae T, Yanagawa M, Kamagata K, Fujita S, Ueda D, et al. Revolutionising radiation therapy: The role of AI in clinical practice. J Radiat Res 2024; 65: 1-9.
  8. Fiandra C, Zara S, Richetto V, Rossi L, Leonardi MC, Ferrari P, et al. Multi-centre real-world validation of automated treatment planning for breast radiotherapy. Phys Med 2024; 123: 103394.
  9. Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 2024; 385: 078378.
  10. Chen D, Arnold K, Sukhdeo R, Alla JF, Raman S. Concordance with CONSORT-AI guidelines in reporting of randomised controlled trials investigating artificial intelligence in oncology: a systematic review. BMJ Oncol 2025; 4: 000733.
  11. Hoang DT, Dinstag G, Shulman ED, Hermida LC, Ben-Zvi DS, Elis E, et al. A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics. Nat Cancer 2024; 5: 1305-1317.
  12. Mohamadi Z, Shafizadeh A, Aliyan Y, Shayesteh SF, Goudarzi P, Khodabandeh A, et al. The application of random forest-based models in prognostication of gastrointestinal tract malignancies: a systematic review. Front Artif Intell 2025; 8: 1517670.
  13. Zhang X, Xian S, Huang D, Cui N, Li J. Development and validation of a gradient boosting machine-based model for predicting tumour-infiltrating lymphocyte proportions in breast cancer. Am J Transl Res 2025; 17: 5586-5601.
  14. Flack D, Tripathi A, Waqas A, Rasool G, Dera D. Robust multimodal fusion for survival prediction in cancer patients. Cancer Inform 2025; 24: 11769351251376192.
  15. Al Marouf A, Rokne JG, Alhajj R. Integrating multi-omics and medical imaging in artificial intelligence-based cancer research: an umbrella review of fusion strategies and applications. Cancers 2025; 17: 3638.
  16. Kazerooni AF, Kraya A, Rathi KS, Kim MC, Vossough A, Khalili N, et al. Multiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade glioma. Nat Commun 2025; 16: 340.
  17. Zeng L, Liu L, Chen D, Lu H, Xue Y, Bi H, et al. The innovative model based on artificial intelligence algorithms to predict recurrence risk of patients with postoperative breast cancer. Front Oncol 2023; 13: 1117420.
  18. Salmanpour MR, Mehrnia SS, Ghandilu SJ, Falahati S, Taeb S, Mousavi G, et al. Handcrafted vs. deep radiomics vs. fusion vs. deep learning: a comprehensive review of machine learning- based cancer outcome prediction in PET and SPECT imaging. arXiv [Preprint] 2025; 2507:16065.
  19. Tagad DD, Babar AS, Jagtap AA, Khamakar PJ. Machine learning and AI in cancer prognosis prediction and treatment selection. Int J Sci Technol 2025; 16: 1-11.
  20. Gou X, Feng A, Feng C, Cheng J, Hong N. Imaging genomics of cancer: a bibliometric analysis and review. Cancer Imaging 2025; 25: 24.
  21. Majumder S, Katz S, Kontos D, Roshkovan L. State of the art: radiomics and radiomics-related artificial intelligence on the road to clinical translation. BJR Open 2024; 6: tzad004.
  22. He W, Huang W, Zhang L, Wu X, Zhang S, Zhang B. Radiogenomics: bridging the gap between imaging and genomics for precision oncology. MedComm 2024; 5: 722.
  23. Gong J, Wang T, Wang Z, Chu X, Hu T, Li M, et al. Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model. Cancer Imaging 2024; 24: 1.
  24. Esfahani HH, Toyonaga S, Oyibo K. The application of explainable artificial intelligence in the prediction, diagnosis, treatment, and management of chronic diseases: a systematic review. Digit Health 2025; 11: 20552076251355669.
  25. Ghasemi A, Hashtarkhani S, Schwartz DL, Shaban-Nejad A. Explainable artificial intelligence in breast cancer detection and risk prediction: a systematic scoping review. Cancer Innov 2024; 3: 136.
  26. Keyl P, Keyl J, Mock A, Dernbach G, Mochmann LH, Kiermeyer N, et al. Neural interaction explainable AI predicts drug response across cancers. NAR Cancer 2025; 7: zcaf029.
  27. Abbas S, Asif M, Rehman A, Alharbi M, Khan MA, Elmitwally N. Emerging research trends in artificial intelligence for cancer diagnostic systems: a comprehensive review. Heliyon 2024; 10: 36743.
  28. Erdur AC, Rusche D, Scholz D, Kiechle J, Fischer S, Llorián-Salvador Ó, et al. Deep learning for autosegmentation for radiotherapy treatment planning: State-of-the-art and novel perspectives. Radiother Oncol 2025; 201: 236-254.
  29. Ilderbayev O, Okassova A, Rakhyzhanova S, Ilderbayeva G, Zhazykbayeva L. The levels of oxidative stress in a combination of stress factors. J Med Life 2022; 2022: 927-931.
  30. Rong Y, Chen Q, Fu Y, Yang X, Al-Hallaq HA, Wu QJ, et al. NRG oncology assessment of artificial intelligence deep learning-based auto-segmentation for radiation therapy: Current developments, clinical considerations, and future directions. Int J Radiat Oncol Biol Phys 2024; 119: 261-280.
  31. Carles M, Kuhn D, Fechter T, Baltas D, Mix M, Nestle U, et al. Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumours on PET and CT images with and without respiratory motion compensation. Eur Radiol 2024; 34: 6701-6711.
  32. Ciancio FF, Insalaco G, Millan S, Randazzo C, Grasso F, Trombetta G, et al. Stage II endometrial cancer: The diagnostic power of hysteroscopic excisional biopsy and MRI in the pre-operative cervical stroma assessment. Eur J Obstet Gynecol Reprod Bio 2024; 298: 140-145.
  33. Kächele J, Zenk M, Rokuss M, Ulrich C, Wald T, Maier-Hein KH. Enhanced nnU-Net architectures for automated MRI segmentation of head and neck tumours in adaptive radiation therapy. In: Wahid KA, Dede C, Naser MA, Fuller CD, editors. Head and neck tumor segmentation for MR-guided applications. Cham: Springer; 2025. p. 50-64.
  34. Celeghin A, Borriero A, Orsenigo D, Diano M, Méndez Guerrero CA, Perotti A, et al. Convolutional neural networks for vision neuroscience: significance, developments, and outstanding issues. Front Comput Neurosci 2023; 17: 1153572.
  35. Gao Y, Park YK, Jia X. Human-like intelligent automatic treatment planning of head and neck cancer radiation therapy. Phys Med Biol 2024; 69: 115049.
  36. Kornovski Y, Ismail E, Kaneva M. Oncological outcomes of combined therapy in patients with cervical carcinoma FIGO stage IIB. Akush Ginekol 2012; 51: 24-29.
  37. Madondo M, Shao Y, Liu Y, Zhou J, Yang X, Tian Z. Patient-specific deep reinforcement learning for automatic replanning in head-and-neck cancer proton therapy. arXiv [Preprint] 2025:2506.10073.
  38. Feng X, Wang M, Lin X, Li C, Pan Y, Zuo G, et al. A new deep learning model for predicting IMRT dose distributions for lung cancer with dose masks. Front Oncol 2025; 15: 1587788.
  39. Mukherjee A, Abraham S, Singh A, Balaji S, Mukunthan KS. From data to cure: a comprehensive exploration of multi-omics data analysis for targeted therapies. Mol Biotechnol 2025; 67: 1269-1289.
  40. Bogoyavlenskiy A, Alexyuk M, Alexyuk P, Berezin V, Almalki FA, Ben Hadda T, et al. Computer analysis of the inhibition of ACE2 by flavonoids and identification of their potential antiviral pharmacophore site. Molec 2023; 28: 3766.
  41. Tulewicz-Marti E, Stępień-Wrochna B, Maciejewska K, Łodyga M, Karłowicz K, Lewandowski K, et al. Awareness and compliance with the recommendations of primary and secondary prevention of cancer in patients with inflammatory bowel disease. J Pers Med 2023; 13: 913.
  42. Ye B, Fan J, Xue L, Zhuang Y, Luo P, Jiang A, et al. iMLGAM: Integrated machine learning and genetic algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction. iMeta 2025; 4: 70011.
  43. Li Y, Wu X, Fang D, Luo Y. Informing immunotherapy with multi- omics driven machine learning. NPJ Digit Med 2024; 7: 67.
  44. Zilgarayeva A, Smailov N, Pavlov S, Mirzakulova S, Alimova M, Kulambayev B, et al. Optical sensor to improve the accuracy of non-invasive blood sugar monitoring. Indones J Elect Eng Comp Sci 2024; 34: 1489-1498.
  45. Ottaiano A, Scala S, Normanno N, Napolitano M, Capozzi M, Rachiglio AM, et al. Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: The CIFRA study protocol. BMC Canc 2019; 19: 899.
  46. Li J, Hu J, Yang Y, Zhang H, Liu Y, Fang Y, et al. Drug resistance in cancer: molecular mechanisms and emerging treatment strategies. Mol Biomed 2025; 6: 111.
  47. Sharshenbaeva A, Kudaibergenova I, Sayakov U, Djumabaeva F, Lim E. Early complications after combined and complex treatment in patients with stage II B cervical cancer. Eur Health J 2024; 16: 116-121.
  48. McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, et al. International evaluation of an AI system for breast cancer screening. Nature 2020; 577: 89-94.
  49. Choi SH, Kim E, Heo SJ, Seol MY, Chung Y, Yoon HI. Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning. Clin Transl Radiat Oncol 2024; 48: 100819.
  50. Abdollahi H, Dehesh T, Abdalvand N, Rahmim A. Radiomics and dosiomics-based prediction of radiotherapy-induced xerostomia in head and neck cancer patients. Int J Radiat Biol 2023; 99: 1669-1683.
  51. Chu H, de Vette SPM, Neh H, Sijtsema NM, Steenbakkers RJHM, Moreno A, et al. Three-dimensional deep learning normal tissue complication probability model to predict late xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2025; 121: 269-280.
  52. Genovese F, Zambrotta E, Incognito GG, Gulino FA, Di Guardo F, Genovese D, et al. Techniques and endocrine-reproductive outcomes of ovarian transposition prior to pelvic radiotherapy in both gynecologic and non-gynecologic cancers: A systematic review and meta-analysis. Int J Gynecol Obstet 2024; 165: 948-958.
  53. Yagi R, Goto S, Himeno Y, Katsumata Y, Hashimoto M, MacRae CA, et al. Artificial intelligence-enabled prediction of chemotherapy- induced cardiotoxicity from baseline electrocardiograms. Nat Commun 2024; 15: 2536.
  54. Ankolekar A, Boie S, Abdollahyan M, Gadaleta E, Hasheminasab SA, Yang G, et al. Advancing breast, lung and prostate cancer research with federated learning: a systematic review. NPJ Digit Med 2025; 8: 314.
  55. Kang J, Chowdhry AK, Pugh SL, Park JH. Integrating artificial intelligence and machine learning into cancer clinical trials. Semin Radiat Oncol 2023; 33: 386-394.
  56. Ottaiano A, Scala S, Santorsola M, Trotta AM, D’Alterio C, Portella L, et al. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. Ther Adv Med Oncol 2021; 13.
  57. Santos CS, Amorim-Lopes M. Externally validated and clinically useful machine learning algorithms to support patient-related decision-making in oncology: a scoping review. BMC Med Res Methodol 2025; 25: 45.
  58. Faenza M, Molle M, Mazzarella V, Antonetti AM, Filosa FG, Pelella T, et al. Functional and aesthetic comparison between grafts and local flaps in non-melanoma skin cancer surgery of the face: a cohort study. JPRAS Open 2024; 42: 97-112.
  59. Yuan H. Toward real-world deployment of machine learning for health care: External validation, continual monitoring, and randomised clinical trials. Health Care Sci 2024; 3: 360-364.
  60. Tulewicz-Marti E, Stępień-Wrochna B, Maciejewska K, Łodyga M, Karłowicz K, Lewandowski K, et al. Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease. J Pers Med 2023; 13: 913.
  61. Kornovski Y, Ismail E. Surgical staging and lymph node status in patients with invasive cervical cancer. Akush Ginekol 2015; 54: 17-21.
  62. Weinberger N, Hery D, Mahr D, Adler SO, Stadlbauer J, Ahrens TD. Beyond the gender data gap: co-creating equitable digital patient twins. Front Digit Health 2025; 7: 1584415.
  63. Górecki S, Tatka A, Brusey J. Artificial intelligence and new technologies in melanoma diagnosis: a narrative review. Cancers 2025; 17: 3896.
  64. Nardone V, Marmorino F, Germani MM, Cichowska-Cwalińska N, Menditti VS, Gallo P, et al. The role of artificial intelligence on tumor boards: perspectives from surgeons, medical oncologists and radiation oncologists. Curr Oncol 2024; 31: 4984-5007.
  65. Jolueva P, Askarov U. The role of artificial intelligence in medicine: a system analysis of opportunities, challenges, and prospects. Eur Health J 2025; 17: 31-37.
  66. Froicu EM, Creangă-Murariu I, Afrăsânie VA, Gafton B, Alexa-Stratulat T, Miron L, et al. Artificial intelligence and decision-making in oncology: a review of ethical, legal, and informed consent challenges. Curr Oncol Rep 2025; 27: 1002-1012.
  67. Ichiuji M, Asakura L, Cain C, Aye N, Kolevska T, Chen D, et al. Improving routine use of clinical pathway decision support through integration of an EHR with a clinical library resource designed to provide evidence-based guidance within oncology workflows. BMC Health Serv Res 2024; 24: 560.
  68. Thind BS, Tsao CK. Artificial intelligence in oncology: Promise, peril, and the future of patient-physician interaction. Front Digit Health 2025; 7: 1633577.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications